NCT00681343View on ClinicalTrials.gov

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2007

Conditions
Living-Donor Kidney Transplant
Interventions
DRUG

Thymoglobulin

Induction

DRUG

Campath-1H

Induction

DRUG

Daclizumab

Induction

Trial Locations (1)

33136

University of Miami Division of Transplantation, Miami

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Miami

OTHER

NCT00681343 - Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation | Biotech Hunter | Biotech Hunter